|
 |
New Anticoagulants in Cardiac Surgery
JJCB Ad, KA Pieter... - 2011 - Abstract Antiplatelet and anticoagulant therapy is a key part of the management of patients undergoing cardiac surgery and one of the cornerstones to prevent complications after coronary bypass or valvular heart surgery. The use of anticoagulants and antiplatelets is ...
Telmisartan in High Cardiovascular Risk Patients The Evolution of Ventricular Assist Devices and the Heart Ware® Ventricular Assist System Transvenous Phrenic Nerve Stimulation – A Novel Therapy for Central Sleep Apnoea in Heart Failure Interventional Bifurcation Individualised Antiplatelet Therapy – Is There a Role for Platelet Function Testing in Routine Clinical Practice? What Would Be the Ideal Drug-eluting Stent for Managing Patients with Long Lesions? A Comparison of Drug-eluting Stents for Percutaneous Coronary Intervention – Background, Rationale and Design of the COMPARE Trial A Medicines Management Review of Treprostinil Sodium (Remodulin®) in Pulmonary Arterial Hypertension The Transformation to Value-based, Personalized Healthcare—Implications for Translational and Clinical Research Reducing the Impact of Congestive Heart Failure through Remote Monitoring of Patient Weight Data
More Details:
New Anticoagulants in Cardiac Surgery |
|
|
